
Sign up to save your podcasts
Or


Based on Podcast App listening data
Catching AxSpA Early: Closing the Diagnostic Gap
Early Peripheral SpA: Is it okay to stop treatment sometimes?
Difficult to Manage axSpA
Tofacitinib in AxSpA in Developing Countries
Late-Breaking Trials in axSpA and PsA
Durability and Safety of Bimekizumab
Biologics Improve Sexual Function in axSpA
Multidimensional Pain inventory in Axial SpA
Spondyloarthritis: The CLASSIC Study
Change it or Keep it? TNF in Axial SpA
"Leftover Pain in Inflammatory Arthritis"
B Cell Depletion: Check the Lymph Node
"Next Generation T-Cell Engager: The Future"
Off the Shelf: CAR-T
Combining CAR-T with CAR-Treg All in One
CAR-T Therapy: Where is it Heading?
Safety of CAR-T
New Paradigms in RA Treatment
Perspectives on CAR T Therapy
Wired for Success: Vagal Nerve Therapy in RA
RA: Does upfront TNFi save heartache?
New Paradigms in RA Treatment
SLGT-2 and GLP-1 in RA: More than Weight Loss
ACR2025 Day 1 RECAP
Cellular Biomarkers of Rheumatoid Arthritis
Day 2 Recap: ACR Convergence 2025 Highlights
STOP RA Cellular & Serologic Predictors
Rheumatoid Arthritis: Inject the Steroids
Is Low Disease Activity Low Enough?
Catching PsA before it Starts
Day 2 Recap: ACR Convergence 2025 Highlights
PsA and Brain Fog
GLP-1 Receptor Agonists in PsA: Mortality and MACE
PsA Predictors
When the Back Hurts: uncovering BASDAI drivers in PsA
The Upper Hand in PsA? Not the Dominant One
Diagnostic Delays in PsA: A Radiographic Perspective
Late-Breaking Trials in axSpA and PsA
New Approaches to Therapy in PsA
Psoriatic Arthritis Imaging
Specialized Biomarkers in PsA
PsA: Impact of Sex
GLP-1 and SGLT-2: Treatments Too Good to Ignore?
From the publisher's feed
Ranked by our users in the last 21 days

698 Listeners

496 Listeners

264 Listeners

3,344 Listeners

1,159 Listeners

116 Listeners

121 Listeners

196 Listeners

522 Listeners

373 Listeners

68 Listeners

5 Listeners

182 Listeners

19 Listeners

6 Listeners